GSK's weight loss drug orlistat 60mg gets non-prescription licence from EU
Friday, January 23, 2009 10:00 IST London
GlaxoSmithKline (GSK) has received a non-prescription licence from European Commission (EU) for alli (orlistat 60mg); the first time the European Commission has approved a non-prescription product for weight loss.